EurekaMag.com logo
+ Site Statistics
References:
52,725,316
Abstracts:
28,411,598
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on Google+Follow on Google+
Follow on LinkedInFollow on LinkedIn

+ Translate

The continued occurrence of primary Pneumocystis carinii pneumonia despite the availability of prophylaxis


Clinical Infectious Diseases 24(3): 522-523
The continued occurrence of primary Pneumocystis carinii pneumonia despite the availability of prophylaxis


Accession: 002980820

PMID: 9114218

DOI: 10.1093/clinids/24.3.522



Related references

HIV-associated Pneumocystis carinii pneumonia, primary pentamidine inhalation prophylaxis notwithstanding. Are there differences with Pneumocystis carinii pneumonia without prophylaxis?. Deutsche Medizinische Wochenschrift 121(4): 83-89, 1996

Prophylaxis against Pneumocystis carinii pneumonia among children with perinatally acquired human immunodeficiency virus infection in the United States. Pneumocystis carinii Pneumonia Prophylaxis Evaluation Working Group. New England Journal of Medicine 332(12): 786-790, 1995

Primary and secondary prophylaxis of Pneumocystis carinii pneumonia with pentamidine aerosol. Efficacy, side effects and frequency of extrapulmonary Pneumocystis carinii manifestation. Medizinische Klinik 89(3): 132-135, 1994

Effect of trimethoprim-sulfamethoxazole as Pneumocystis carinii pneumonia prophylaxis on bacterial illness, Pneumocystis carinii pneumonia, and death in persons with AIDS. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology 20(2): 201-206, 1999

Primary prophylaxis against Pneumocystis carinii pneumonia. New England Journal of Medicine 328(20): 1499-1499, 1993

Primary and secondary prophylaxis against pneumocystis carinii pneumonia with fansidar. Morisset, R A (Ed ) Ve Conference Internationale Sur Le Sida: Le Defi Scientifique Et Social; V International Conference on Aids: The Scientific And Social Challenge; Montreal, Quebec, Canada, June 4-9, 1262p International Development Research Centre: Ottawa, Ontario, Canada Illus Paper 290, 1989

Discontinuation of primary prophylaxis for Pneumocystis carinii pneumonia and toxoplasmic encephalitis in human immunodeficiency virus type 1-infected patients: The changes in opportunistic prophylaxis study. Journal of Infectious Diseases 181(5): 1635-1642, May, 2000

Discontinuation of primary prophylaxis for Pneumocystis carinii pneumonia and toxoplasmic encephalitis in human immunodeficiency virus type I-infected patients: the changes in opportunistic prophylaxis study. Journal of Infectious Diseases 181(5): 1635-1642, 2000

Does primary prophylaxis alter the face of pneumocystis carinii pneumonia pcp in aids. Istituto Superiore Di Sanita Vii International Conference on Aids: Science Challenging Aids; Florence, Italy, June 16-21, 464p (Vol 1); 460p (Vol 2) Istituto Superiore Di Sanita: Rome, Italy Paper : 230b, 1991

Fansidar for the primary prophylaxis of Pneumocystis carinii pneumonia and toxoplasma encephalitis. IXTH INTERNATIONAL CONFERENCE ON AIDS AND THE IVTH STD WORLD CONGRESS [Author] IXth International Conference on AIDS in affiliation with the IVth STD World Congress : 57, 1993